The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Cardiome Pharma Corp down $0.21

Cardiome Pharma Corp closed sharply lower Friday, dropping $0.21 or 2.63% to $7.79. Over the last five days, shares have lost 15.78% and are down 30.01% for the last year to date. This security has underperformed the S&P TSX by 18.15% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.88
Updated February 5 3:58 PM EST. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Total other revenue--------
Total revenue5657
Gross profit4543
Total cost of revenue1114
Total operating expense1013813
Selling / general / administrative8869
Research & development0300
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-5-7-3-6
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Income before tax-6-7-4-7
Income after tax-6-7-4-6
Income tax, total0000
Net income-6-7-4-6
Total adjustments to net income--------
Net income before extra. items-6-7-4-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-7-4-6
Inc. avail. to common incl. extra. items-6-7-4-6
Diluted net income-6-7-4-6
Dilution adjustment--------
Diluted weighted average shares19171717
Diluted EPS excluding extraordinary itemsvalue per share-0.31-0.43-0.23-0.39
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.31-0.43-0.23-0.39